CNMD — CONMED Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 816956 ·
Last close
$45.38
Market Cap
$1.36B
52W High
$53.66
52W Low
$31.44
ADV30
328,093
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 343,488,000 | 197,458,000 | 36,405,000 | 23,071,000 | 2,300,306,000 | 37,328,000 | 1,258,916,000 |
| Mar 2026 | 317,046,000 | 183,447,000 | 25,415,000 | 13,828,000 | 2,314,942,000 | 35,030,000 | 1,297,269,000 |
| Dec 2025 | 373,198,000 | 218,285,000 | 36,624,000 | 16,739,000 | 2,325,749,000 | 40,817,000 | 1,292,652,000 |
| Sep 2025 | 337,926,000 | 166,119,000 | 11,879,000 | 2,859,000 | 2,322,488,000 | 38,929,000 | 1,314,225,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$150,588,000
Investing CF
$3,376,000
Financing CF
$-149,682,000
CapEx
$-16,124,000
Dividends Paid
$-12,380,000
Buybacks
$-43,221,000
EPS Diluted TTM
$1.85
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$625,665,000
Inventory
$360,179,000
Receivables
$239,770,000
ST Investments
—
EBIT TTM
$113,148,000
Pretax Income TTM
$83,228,000
Interest Exp TTM
$29,920,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,371,657,984
EBITDA
$227,460,992
Free Cash Flow
$131,359,624
Enterprise Value
$2,183,663,872
Total Cash
$37,328,000
Total Debt
$834,249,024
Shares Out
29,951,248
Trailing EPS
$1.85
Book Value
$34.73
ROE
5.5%
ROA
4.1%
Div Yield
1.73%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,374,724,000 | 102,622,000 | 47,055,000 | 2,325,749,000 | 1,292,652,000 | 1,033,097,000 | 170,689,000 |
| Dec 2024 | 1,307,015,000 | 200,326,000 | 132,423,000 | 2,306,247,000 | 1,343,566,000 | 962,681,000 | 166,968,000 |
| Dec 2023 | 1,244,744,000 | 120,603,000 | 64,459,000 | 2,300,021,000 | 1,465,799,000 | 834,222,000 | 125,348,000 |
| Dec 2022 | 1,045,472,000 | 70,054,000 | -80,582,000 | 2,297,592,000 | 1,552,047,000 | 745,545,000 | 33,365,000 |
TTM Snapshot
Revenues TTM
$1,217,623,000
NetIncome TTM
$117,007,000
OpCashFlow TTM
$0
Assets (Latest)
$2,325,749,000
Forward EPS
$4.78
Max Pain — expiry 2026-10-16
max pain strike: $45.00 · spot: $45.38 · call oi: 912 · put oi: 107
Expected Move to 2026-10-16:
±$3.52
(7.76%) —
implied range
$41.86 –
$48.90
· ATM straddle on $45.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DRTS | Alpha Tau Medical Ltd. | $1.34B | $14.54 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.25B | $16.12 | — |
| ATEC | Alphatec Holdings, Inc. | $1.56B | $10.12 | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.59B | $27.14 | — |
| CDRE | Cadre Holdings, Inc. | $1.13B | $26.39 | — |
News headlines (Yahoo Finance, 1h cache)
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
2026-09-16 16:18 · Yahoo
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
2026-08-28 15:30 · Yahoo
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
2026-08-26 20:05 · Yahoo
The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio
2026-08-18 11:10 · Yahoo
CNMD Jumps 16% in a Month as Investors Assess Whether It Can Last
2026-08-17 19:12 · Yahoo
Can CONMED's Raised 2026 EPS Outlook Reinforce Its Growth Momentum?
2026-08-17 19:06 · Yahoo
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
2026-08-17 19:05 · Yahoo
Why Are CONMED (CNMD) Shares Soaring Today
2026-07-30 22:13 · Yahoo
CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
2026-07-30 16:49 · Yahoo
CONMED Q2 Earnings Call Highlights
2026-07-30 02:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.